Search research articles
Contact Us
Filters
Showing results (1-10 of 39) with videos related to
Page
of 4
Sort By:
Journal of Surgical Oncology
|
April 12, 2011
Targeting the growth factors and angiogenesis pathways: small molecules in solid tumors
David Berz, Harold Wanebo
Journal of Surgical Oncology
|
December 18, 2010
The neoadjuvant therapy of colorectal hepatic metastases and the role of biologic sensitizing and resistance factors
Harold J Wanebo, David Berz
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 2008
Extreme hyperlymphocytosis
David Berz, Nancy J Freeman
Cancer Treatment and Research
|
October 24, 2007
Targeting small molecules in cancer
Harold J Wanebo, David Berz, Anthony Mega
Breast Cancer Research and Treatment
|
May 21, 2008
'Weighing in' on screening mammography
David Berz, William Sikov, Gerald Colvin, et al.
Expert Opinion on Therapeutic Targets
|
February 15, 2007
HER family inhibitors in pancreatic cancer: current status and future directions
David Berz, Thomas Miner, Elise McCormack, et al.
Medicine and Health, Rhode Island
|
February 5, 2011
Pesticides and non-Hodgkin lymphoma: an overview for the clinician
David Berz, Jorge J Castillo, Daniela N Quilliam, et al.
Case Reports in Oncology
|
November 30, 2011
Cremophor-induced lupus erythematosus-like reaction with taxol administration: a case report and review of the literature
Anthony Q Pham, David Berz, Patricia Karwan, et al.
Medicine and Health, Rhode Island
|
January 11, 2011
Alphabet soup: RAEB, HMA, DOE, and AFOP
Nathan T Connell, Heather M Cassidy, David Berz, et al.
Experimental Hematology & Oncology
|
August 11, 2016
Non-invasive urine testing of EGFR activating mutation and T790M resistance mutation in non-small cell lung cancer
David Berz, Victoria M Raymond, Jordan H Garst, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 39) with videos related to
Sort By:
Page
of 4
Journal of Surgical Oncology
|
April 12, 2011
Targeting the growth factors and angiogenesis pathways: small molecules in solid tumors
David Berz, Harold Wanebo
Journal of Surgical Oncology
|
December 18, 2010
The neoadjuvant therapy of colorectal hepatic metastases and the role of biologic sensitizing and resistance factors
Harold J Wanebo, David Berz
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 2008
Extreme hyperlymphocytosis
David Berz, Nancy J Freeman
Cancer Treatment and Research
|
October 24, 2007
Targeting small molecules in cancer
Harold J Wanebo, David Berz, Anthony Mega
Breast Cancer Research and Treatment
|
May 21, 2008
'Weighing in' on screening mammography
David Berz, William Sikov, Gerald Colvin, et al.
Expert Opinion on Therapeutic Targets
|
February 15, 2007
HER family inhibitors in pancreatic cancer: current status and future directions
David Berz, Thomas Miner, Elise McCormack, et al.
Medicine and Health, Rhode Island
|
February 5, 2011
Pesticides and non-Hodgkin lymphoma: an overview for the clinician
David Berz, Jorge J Castillo, Daniela N Quilliam, et al.
Case Reports in Oncology
|
November 30, 2011
Cremophor-induced lupus erythematosus-like reaction with taxol administration: a case report and review of the literature
Anthony Q Pham, David Berz, Patricia Karwan, et al.
Medicine and Health, Rhode Island
|
January 11, 2011
Alphabet soup: RAEB, HMA, DOE, and AFOP
Nathan T Connell, Heather M Cassidy, David Berz, et al.
Experimental Hematology & Oncology
|
August 11, 2016
Non-invasive urine testing of EGFR activating mutation and T790M resistance mutation in non-small cell lung cancer
David Berz, Victoria M Raymond, Jordan H Garst, et al.
Page
of 4